Agilent Technologies, Inc. (A)

Agilent Technologies, Inc. (A) is a healthcare company (diagnostics & research) based in the United States. The share price is $172.66, down 0.15% on the day, which values the company at $48.68B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.

Key facts

Share price
$172.66−0.15% today
Market value
$48.68B
P/E ratio
34.1×last 12 months
Forward P/E
25.7×
Dividend yield
0.59%
Funk Score
55/100
Against its own history
Well above its usual priceusual price $105.64
200-week average
$132.6130% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Agilent Technologies, Inc. in more detail

A trades at 34.1× its last twelve months' earnings, 25.7× next year's expected earnings, 6.6× sales. Measured against its own history, the price is 63% above what its usual multiples would imply ($105.64) — well above its usual price. It sits 30% above its 200-week average of $132.61.

Over the last five fiscal years Agilent Technologies, Inc. has compounded revenue 5.4% a year, earnings per share 14.7% a year, free cash flow 7.5% a year. Its Funk Score is 55 out of 100 (financial strength 7.4, profitability 7.2, growth 4.5, value 2.9, each out of 10).

In its favour: Altman Z in the safe zone; Share count keeps falling.

4 of the superinvestors tracked here hold A, including Larry Robbins (5.2% of the portfolio), Cliff Asness (0.2% of the portfolio), Primecap team (0.1% of the portfolio).

Superinvestors holding A

4 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:A vs TEVA (Agilent Technologies, Inc. vs Teva Pharmaceutical Industries)A vs HUM (Agilent Technologies, Inc. vs Humana)A vs MDLN (Agilent Technologies, Inc. vs Medline)A vs ONC (Agilent Technologies, Inc. vs BeOne Medicines)A vs IDXX (Agilent Technologies, Inc. vs IDEXX Laboratories)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Agilent Technologies, Inc. (A): questions and answers

What is A's P/E ratio?

Agilent Technologies, Inc. trades at 34.1× its last twelve months' earnings and 25.7× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 7.9× to 66.8×, with a median of 27.0×.

What is A's PEG ratio?

Agilent Technologies, Inc.'s PEG ratio is 1.47 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Agilent Technologies, Inc.'s market cap?

Agilent Technologies, Inc. is valued at $48.68B at a share price of $172.66.

Is A overvalued or undervalued?

Against its own history, A is well above its usual price: the price is 63% above the $105.64 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is A above its 200-week moving average?

Yes. A is 30.2% above its 200-week average of $132.61. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Agilent Technologies, Inc. growing?

Over the last five fiscal years Agilent Technologies, Inc.'s revenue grew 5.4% a year and its earnings per share 14.7% a year; over ten years revenue grew 5.6% a year.

Cite this page

Funkfolio, “Agilent Technologies, Inc. (A) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/A

Underlying data: Yahoo Finance; company filings with the SEC.